Abstract
We report a case of superior mesenteric artery thrombosis in a 57-year-old woman undergoing chemotherapy for T1N1M0, breast cancer. Although cancer itself is associated with an increased risk of thrombotic events, treatment with chemotherapy and/or tamoxifen in breast cancer patients increases this risk. Most cases reported are of venous thromboembolism; arterial events are rare.
MeSH terms
-
Abdomen, Acute / chemically induced*
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
-
Breast Neoplasms / drug therapy
-
Chemotherapy, Adjuvant
-
Cyclophosphamide / adverse effects*
-
Female
-
Fluorouracil / adverse effects*
-
Humans
-
Mesenteric Artery, Superior / drug effects
-
Mesenteric Vascular Occlusion / chemically induced*
-
Methotrexate / adverse effects*
-
Middle Aged
-
Thrombosis / chemically induced*
Substances
-
Cyclophosphamide
-
Fluorouracil
-
Methotrexate